Lei Dou Selected Research

Lei Dou Research Topics

Disease

14	Neoplasms (Cancer) 07/2023 - 03/2016
5	Ovarian Neoplasms (Ovarian Cancer) 07/2023 - 01/2015
4	Esophageal Squamous Cell Carcinoma 01/2024 - 01/2022
3	Carcinogenesis 01/2021 - 03/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2023 - 01/2023
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 05/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 03/2016
2	Infections 01/2018 - 01/2018
2	Reperfusion Injury 06/2015 - 01/2014
1	Dental Pulp Necrosis 03/2024
1	Acute Lung Injury 12/2023
1	Bacterial Infections (Bacterial Infection) 10/2023
1	Myopia 07/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2023
1	Coronary Disease (Coronary Heart Disease) 01/2023
1	Periodontitis 01/2023
1	Fatigue 06/2022
1	Methemoglobinemia 01/2022
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2022
1	Hemolytic Anemia 01/2022
1	Adenocarcinoma 01/2022
1	Colitis 01/2021
1	Osteoporosis 01/2021
1	Lymphatic Metastasis 01/2020
1	Erectile Dysfunction 12/2019
1	Periapical Diseases 09/2018
1	Hemorrhage 07/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Pain (Aches) 01/2018
1	Vascular System Injuries 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Pathologic Processes 01/2018
1	Periodontal Diseases (Periodontal Disease) 01/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2015
4	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2016
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2023
2	NivolumabIBA 01/2024 - 01/2022
2	Cisplatin (Platino)FDA LinkGeneric 07/2023 - 01/2021
2	AlbuminsIBA 10/2022 - 01/2022
2	Long Noncoding RNAIBA 01/2020 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 03/2015
1	sintilimabIBA 01/2024
1	pembrolizumabIBA 01/2024
1	camrelizumabIBA 01/2024
1	Programmed Cell Death 1 ReceptorIBA 01/2024
1	tislelizumabIBA 01/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2023
1	Toll-Like Receptor 9IBA 12/2023
1	DNA (Deoxyribonucleic Acid)IBA 12/2023
1	Anti-Infective Agents (Microbicides)IBA 10/2023
1	Cell-Penetrating PeptidesIBA 10/2023
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 09/2023
1	phytobacteriomycin (PBM)IBA 07/2023
1	AdrenomedullinIBA 07/2023
1	Glucose (Dextrose)FDA LinkGeneric 07/2023
1	PlatinumIBA 07/2023
1	B7-H1 AntigenIBA 01/2023
1	baricitinibIBA 01/2022
1	IpilimumabIBA 01/2022
1	SolutionsIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	NAD (NADH)IBA 01/2022
1	beta-lapachoneIBA 01/2022
1	quinone (benzoquinone)IBA 01/2022
1	EnzymesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	5-ethynyl-2'-deoxyuridineIBA 12/2021
1	Antineoplastic Agents (Antineoplastics)IBA 12/2021
1	bufalinIBA 12/2021
1	BromidesIBA 12/2021
1	Amphibian VenomsIBA 12/2021
1	Chaperonin Containing TCP-1IBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	AntioxidantsIBA 01/2021
1	osthol (osthole)IBA 01/2021
1	CopperIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	mKateIBA 12/2019
1	LuciferasesIBA 12/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2018
1	ProteomeIBA 01/2018
1	SurvivinIBA 03/2016
1	AntimetabolitesIBA 03/2016
1	Fluorouracil (Carac)FDA LinkGeneric 03/2016
1	Complementary DNA (cDNA)IBA 03/2016

Therapy/Procedure

10	Therapeutics 01/2024 - 01/2018
6	Drug Therapy (Chemotherapy) 01/2024 - 01/2015
2	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2024 - 01/2021
1	Regenerative Endodontics 03/2024
1	Percutaneous Coronary Intervention 01/2023
1	Uterine Myomectomy 06/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2021
1	Immunotherapy 08/2021
1	Hepatectomy 07/2018
1	Transplantation 01/2018
1	Endodontics 01/2018